Genu Recurvatum Market: In-Depth Research on Market Dynamics, Applications & Emerging Growth Factors

 

It is estimated that congenital genu recurvatum Market is expected to grow at a CAGR 4.5% during the forecast period of 2017-2023.

Genu recurvatum is also known as knee hyperextension or back knee. It is a type of condition that affects the knee joint to bend backward when the person is in standing position. This problem is more common in women than in men and commonly identified in 0.5%-1.0% of patients undergoing Total knee arthroplasty (TKA). This condition leads to stress in the posterior knee structures and anterior cruciate ligaments (ACL) which cause permanent damage of the joint. Genu recurvatum can also cause other conditions such as knee pain or knee osteoarthritis. Genu recurvatum can be mild, moderate, or severe. This deformity can also arise from other medical conditions such as, quadriceps weakness, bone deformities, paralysis, plantar foot flexion, and high tibial ostotomies. Genu recurvatum can be congenital or acquired. Congenital genu recurvatum (CGR) is extremely rare condition, and found to be associated with other malformations such as talipes equinovarus, hip dysplasia, and absent patella. Rising geriatric population, high unmet needs of current treatment, and increase in research and development expenditure will promote the growth of genu recurvatum market. According to the data suggested by WHO in 2015, it is found that, worldwide, one in eight people was aged 60 years or over and by 2030, older people are projected to account for one in six people globally. High cost of treatment & management genu recurvatum and related disorders, and lack of infrastructure in the middle and low income countries may hinder the growth of the market.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/4812

Regional Analysis

The Americas dominate the Genu recurvatum market owing to the rising awareness among people, and increasing healthcare expenditure. Centers for Disease Control and Prevention (CDC) has stated that out of the total annual healthcare expenditure, 86% is for people with chronic health conditions in the United States. Furthermore, increasing participation of bigger players and new marketers towards advancement in treatment approaches have also attracted a great deal of attention. Europe holds the second position in the Genu recurvatum market. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in the European region. Asia Pacific is the fastest growing genu recurvatum market owing to the huge patient pool and developing healthcare technology. The Middle East & Africa has the lowest market for rabies treatment market due to lack of technical knowledge and poor medical facilities.

Segmentation

The Genu recurvatum market is segmented on the basis of type, diagnosis, treatment, and end-user. On the basis of type, market is segmented into external rotatory deformity (ERD), internal rotatory deformity (IRD), and non-rotatory deformity (NRD). On the basis of diagnosis, market is segmented into magnetic resonance imaging (MRI), x-rays, and others. On the basis of treatment, market is classified into physical therapy, orthoses, bracing, and surgery. On the basis of end-user, market is segmented into hospital, clinics, and others.

Access Report Details @ https://www.marketresearchfuture.com/reports/genu-recurvatum-market-4812

Key Players Some of key the players in the market are DePuy Synthes Companies (Part of Johnson & Johnson Services, Inc.), Globus Medical, Inc., Medtronic plc, NuVasive, Inc., Smith & Nephew plc, Stryker Corporation, Zimmer Inc and others.

Comments

Post a Comment

Popular posts from this blog

Bone Metastasis Treatment Industry Detailed Analysis, Growth Factors, Top Key Companies, Trends and Developments, 2018-2023

Bone Metastasis Treatment Industry Research Report, by Type (Osteolytic, Osteoblastic, Mixed), Diagnosis (Biopsy, Blood Test, Imaging), Treatment (Medical Therapies, Surgery, Medication), End User (Hospital, Diagnostic Centers) - Global Forecast Till 2023 Market Highlights The global Bone Metastasis Treatment Industry is expected to grow at an approximate CAGR of 8.4% during the forecast period The increasing prevalence of breast cancer, growing geriatric population, rising healthcare expenditures, and increasing R&D expenses by the key players are estimated to drive the market growth during the forecast period. However, factors such as lack of healthcare services in low-income countries, the high cost of treatment, and related side effects are estimated to restrain the market growth during the forecast period. Segmentation The global Bone Metastasis Treatment Industry is segmented on the basis of type, diagnosis, treatment, and end-user. On the basis of type, the m
Read more

heart transplant market : Industry Trends and Developments 2019 – 2027

  Heart Transplant or Heart Implant or Cardiac Transplant surgery market is growing rapidly, enhancing the quality of life of people by delivering miraculous results. Over the past few decades, many innovations have transpired in the field of heart transplant allowing patients an extended lifespan of 13 years approximately with the new heart. The advancement of effective drugs ascended the success rate of heart transplants to further heights allowing the heart transplant market to witness upsurge. Another predominant factor that contributes to the market growth is the growing prevalence of heart failure and severe coronary artery diseases across the globe. Acknowledging the numerous innovations transpired in the  heart transplant market  and the surging traction the market is garnering currently Market Research Future (MRFR) in its recently published study report asserts that the global the Heart Transplant Market is projected to perceive booming accruals by 2023, registering a strikin
Read more

Patient Engagement Solution Market Share Plying for Significant Growth During 2019 – 2025

Market Highlights According to MRFR analysis, the Global  Patient Engagement Solution Market Share  is expected to register a CAGR of 18.90% during the forecast period of 2019 to 2025 and was valued at USD 42,600 million in 2018. Healthcare providers use patient engagement solutions for better access to data for effective self-care. Patient involvement, however, does not only involve technology such as portal as well as automated messaging. The method also plays an essential role in ensuring patient satisfaction. Several hardware, software, and services are used to get patient health information. The growth of global patient engagement solution market a vital by numerous factors such as an augmented application of patient engagement solutions in the healthcare sector, an increasing number of patients suffering from chronic disorders and growing number of insurance holders. However, the cost associated with the implementation of patient engagement solutions and rising cases
Read more